The Role of p16Ink4a as an Early Predictor of Physiological Decline during Natural Aging
Abstract
Cellular senescence is a prominent accomplice of aging. The expression of gene p16ink4a has been established as a biomarker of cellular senescence in humans and animal models. However, it has not been extensively studied in clinical settings in the context of natural aging and the development of age-related diseases. Here, we report the results of a natural aging study that provided an assessment of cellular senescence and a battery of measures of clinical status, quality of life (QOL), and physical performance in 250 community-dwelling participants across age continuum. This report focused on analyzing predictive relationships between cellular senescence and different clinical assessments. Our results suggest that clinical labs and QOL assessments produce distinct groupings of participants, yet both have strong predictive associations with p16ink4a. Furthermore, the highest accuracy of p16ink4a prediction requires subsets of measurements representing diverse aspects of each assessment, pointing towards a system-level role of p16ink4a. Our analysis also led to an assessment-based composite indexes that strongly correlate with p16ink4a expression. Our study underscores p16ink4as association with both earlier signs of physiological decline (based on clinical labs) and the later onset of health issues limiting the quality of life.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper investigates the role of p16Ink4a as a biomarker of cellular senescence in the context of natural aging, which is directly relevant to longevity research and understanding the biological mechanisms of aging. While it presents solid findings regarding the predictive relationships between p16Ink4a and various clinical assessments, the study appears to be more of an incremental advance rather than a groundbreaking discovery. Its contributions to the field are valuable but do not significantly alter the current understanding or approach to aging and longevity.
Author of this paper? Send a correction.